Mydecine Innovations Group Engages ProPharma Group to Proceed with FDA Filings and Approval for Novel Research and Multiple Phase Clinical Trials
DENVER, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research,...
ProPharma Honored in the 2024 Clinical Trials Excellence Awards
ProPharma has been recognized as a dual-category winner in the Clinical Trial Arena Excellence Awards, receiving accolades in both Business Expansion and Mergers & Acquisitions (M&A). These awards...
ProPharma Introduces ClinCHAT, a Solution to Unleash the Power of Real-World Evidence with Conversational AI
Raleigh, NC, September 13, 2023: ProPharma Group (ProPharma), the leading global provider of regulatory, clinical and compliance services for the life sciences industry, and a portfolio company of...